This article is my fifth covering the very under-followed Arcadia Biosciences (RKDA), so for those new to the story, I recommend reading my earlier writings to get up to speed. In summary, my long-term bullish stance has been based on the company's technological platform, one that I believe will use cutting-edge technologies to improve crops of many types.
As the company has evolved, there has been a new focus on vertically integrating within the Industrial Hemp space, a focus which should translate well to marijuana whenever it is fully legalized in the US.